MedPath

Laparoscopic/Robotic-assisted Hysteropexy Versus Vaginal Hysterectomy for the Treatment of Uterovaginal Prolapse

Not Applicable
Conditions
Uterovaginal Prolapse
Hysteropexy
Interventions
Procedure: patient who undergo laparoscopic/robotic-assisted hysteropexy
Procedure: patient who undergo vaginal hysterectomy
Registration Number
NCT02877407
Lead Sponsor
Seoul National University Hospital
Brief Summary

* objective: aimed to compare laparoscopic/robot-assisted hysteropexy with vaginal hysterectomy for uterine prolapse

* prospective randomized clinical trial

* patient

1. 60yrs or more women and

2. POP-Q stage II with symptom or POP-Q III, IV regardless of symptom

* number of patient: 146

* randomize: laparoscopic/robot-assisted hysteropexy vs. hysterectomy

* follow up: postoperative 1 year

* primary endpoint: recurrence rate

1. recurrence of uterovaginal prolapse POP-Q stage II-IV

2. recurrence of associated symptom

* secondary endpoint

1. postoperative 1 year QOL, degree of satisfaction evaluation

2. operative time, estimated blood loss

3. hospitalization period, postoperative pain, return to normal activity

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
146
Inclusion Criteria
  • POP-Q stage II with symptom or POP-Q III, IV regardless of symptom
Exclusion Criteria
  • abnormal uterine bleeding
  • significantly enlarged fibroid uterus
  • postmenopausal uterine bleeding
  • endometrial pathology
  • on tamexifen
  • concomitant medical problems precluding general anesthesia or surgery
  • damaged agreement ability

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
laparoscopic/robotic-assisted hysteropexypatient who undergo laparoscopic/robotic-assisted hysteropexypatient who undergo laparoscopic/robotic-assisted hysteropexy
vaginal hysterectomypatient who undergo vaginal hysterectomypatient who undergo vaginal hysterectomy
Primary Outcome Measures
NameTimeMethod
recurrence rate (%)postoperative 1 year

recurrence rate(%) of uterovaginal prolapse POP-Q stage II-IV in postoperative 1 year

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National Univesity Bundang Hospital

🇰🇷

Seongnam-si, Kyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath